Boston Scientific Corporation
Market Cap
$63.7B
Global Rank
#230
All-Time High
$141.7B
2025-12-31
Total Growth
+0%
since 2026
Market Cap Context
- Larger than 37% of the 367 companies we track (globally).
- Equivalent to 0.2% of United States's GDP (2025 data).
- Just above: #229 Takeda Pharmaceutical Company Limited ($63.9B)
- Just below: #231 Air Products and Chemicals, Inc. ($62.7B)
- Best year: 1995 (+183%). Worst year: 2026 (-55%).
Boston Scientific Corporation Financial Breakdown (FY 2025)
Source: Yahoo Finance โ BSX annual filings (2025) โ$20.1B revenue ยท $4.0B operating income ยท $2.9B net income
- โOperating margin: 19.8% on $20.1B in revenue.
- โR&D is 10.2% of revenue ($2.1B).
- โNet income margin: 14.4% โ $2.9B in profit.
- โFree cash flow: $3.4B (17.0% of revenue).
Cost / Operating Expenses
Total operating expenses $16.1B
Total
$15.2B
Capital Expenditures
$1.1B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$3.4B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
About Boston Scientific Corporation
Boston Scientific Corporation (BSC) is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Boston Scientific Corporation Market Cap History (2026โ2026)
Boston Scientific Corporation vs Sector Peers by Market Cap
Compare Boston Scientific Corporation
Ranking History
| Year | Market Cap | Rank | YoY Change |
|---|---|---|---|
| 2026 | $63.7B | #230(โ118) | -55.1% |
| 2025 | $141.7B | #112(โ14) | +6.8% |
| 2024 | $132.8B | #98(โ34) | +54.5% |
| 2023 | $85.9B | #132(โ1) | +24.9% |
| 2022 | $68.8B | #131(โ22) | +8.9% |
| 2021 | $63.1B | #153(โ12) | +18.2% |
| 2020 | $53.4B | #165(โ63) | -20.5% |
| 2019 | $67.2B | #102(โ8) | +28.0% |
| 2018 | $52.5B | #94(โ66) | +42.6% |
| 2017 | $36.8B | #160(โ18) | +14.6% |
| 2016 | $32.1B | #142(โ6) | +17.3% |
| 2015 | $27.4B | #148(โ46) | +39.2% |
| 2014 | $19.7B | #194(โ8) | +10.2% |
| 2013 | $17.9B | #186(โ36) | +109.8% |
| 2012 | $8.5B | #222(โ15) | +7.3% |
| 2011 | $7.9B | #207(โ27) | -29.5% |
| 2010 | $11.3B | #180(โ37) | -15.9% |
| 2009 | $13.4B | #143(โ23) | +16.3% |
| 2008 | $11.5B | #120(โ8) | -33.4% |
| 2007 | $17.3B | #128(โ59) | -32.3% |
| 2006 | $25.5B | #69(โ28) | -29.8% |
| 2005 | $36.4B | #41(โ25) | -31.1% |
| 2004 | $52.8B | #16(โ1) | -3.3% |
| 2003 | $54.6B | #15(โ11) | +72.9% |
| 2002 | $31.6B | #26(โ35) | +76.3% |
| 2001 | $17.9B | #61(โ32) | +76.2% |
| 2000 | $10.2B | #93(โ34) | -37.4% |
| 1999 | $16.3B | #59(โ18) | -18.4% |
| 1998 | $19.9B | #41(โ3) | +16.9% |
| 1997 | $17.0B | #38(โ17) | -23.5% |
| 1996 | $22.3B | #21(โ1) | +21.8% |
| 1995 | $18.3B | #20(โ12) | +183.5% |
| 1994 | $6.5B | #32 |
Other Healthcare Companies
FAQ
What is Boston Scientific Corporation's market cap?
Boston Scientific Corporation (BSX) has a market capitalization of $63.7B, making it the #230 largest company in the world by market cap.
What was Boston Scientific Corporation's highest market cap?
Boston Scientific Corporation's all-time high market cap was $141.7B, reached in 2025-12-31. Its highest rank was #112 in 2025.
What sector is Boston Scientific Corporation in?
Boston Scientific Corporation is in the Healthcare sector, specifically the Medical Devices industry. It is based in United States.
How has Boston Scientific Corporation's market cap changed over time?
Boston Scientific Corporation has been tracked since 2026. Its market cap has grown by 0% from $63.7B in 2026 to $63.7B today.